FDA Grants Full Approval to Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years
Washington, D.C. (Agencies) July 10, 2025 — The U.S. Food and Drug Administration (FDA) has officially granted full approval to Moderna’s COVID-19 vaccine, Spikevax, for use in children aged 6…